Responsible Institution: China Association for Science and Technology
Sponsored by: The Chinese Pharmacological Society
Editor-in-Chief: HUANG Zhili
ISSN 1009-2501
CN 34-1206/R
Statistic Department of the First Hospital of Peking University, Beijing 100034, China; 1the School of Public Health of Peking University, Beijing 100083, China
LI Xue-ying, KANG Xiao-ping, YAO Chen. Choice of data base structure for clinical trail[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(9): 1076-1080.
1 Sactett D, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS.Evidence Based medicine:what it is and what it isn't [J].BMJ, 1996;312:71-2 2 Bero L, Rennie D.The Cochrane Collaboration, preparing, maintaining, and dissemination, systematic review of the effects of health care[J].JAMA, 1995;274:1935-8 3 CDISC Analysis Dataset Modeling Team.Statistical Analysis Dataset Model:General Considerations Version 0.7 [DB]. 2004:8-9 4 E3 Structure and content of clinical study report, ICH Harmonised Tripartite Guideline[S]. ICH Harmonised Tripartite Guideline[S].1995 5 药物临床试验质量管理规范(局令第3 号)[S].5 药物临床试验质量管理规范(局令第3 号)[S].2003:8 6 CDISC ADaM Working Group.ADaM Model for Time-to-Event Analysis Files[DB].2003:28-40 7 Moore RD, Fortgang L, Keruly J, Chaisson RE.Adverse event from drug therapy for human immunodeficiency virus disease [J].Am J Med, 1996;101:34-40 8 Newman CB, Palmer G, Silbershatz H, SzarekM.Safety of Atorvastatin Derived from Analysis of 44 Completed Trials in 9416 Patients[J].Am J Cardiol, 2003;92:670-6 9 Holzheimer RG, Dralle H.Antibiotic therapy in intra-abdominal infections-A review on randomised clinical trials[J].Eur J Med Res, 2001;6:277-91 10 徐士良.实用数据结构[M].北京:清华大学出版社,2000:140-4